Europe's Most Empowering Side Hustle for Women? QueenZone257 Is Taking Over
Praised as 'Europe's most empowering digital side job for women,' QueenZone257 combines freedom, trust, and real rewards – offering a new standard for what a modern side hustle can be.
'This is not just a job – it's an opportunity,' says Lina H., a 29-year-old from Berlin. 'I complete simple tasks on my phone, test products I actually get to keep, and earn money daily. No fees, no pressure – just honest work.'
The platform, accessible via www.queenzone257.com, offers daily digital tasks and paid product testing jobs designed for women across Germany, Austria, Switzerland, and now the UK.
No professional background is needed – just a smartphone and internet connection. Most tasks take just a few minutes and include app testing, feedback submission, and Goodie Assignments, where users receive real products to try and review.
Unlike many gig platforms, QueenZone257 is: ✅ 100% free to join – no upfront payments or hidden costs
– no upfront payments or hidden costs ✅ Fully GDPR-compliant , ensuring user privacy and data protection
, ensuring user privacy and data protection ✅ Fast-paying – earnings are paid out promptly, with no minimum thresholds
Users are guided through a simple onboarding process via WhatsApp and can choose when and how often they want to work. There are no fixed schedules – the platform adapts to individual lifestyles.
'It's rare to find something online that's actually fair and transparent,' says a London-based user. 'QueenZone257 felt real from day one.'
While many online jobs feel impersonal or exploitative, QueenZone257 emphasizes community, clarity, and flexibility. It's designed to help women earn money without pressure, from wherever they are – whether on the sofa, on the go, or during a quiet moment at home.
Women aged 18–40 can now apply directly at www.queenzone257.com. The application process is digital, fast, and takes only a few minutes. Once accepted, new users typically receive their first assignment within 48 hours.
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
3 hours ago
- News24
Big Tech in SA exposed in chilling WhatsApp, Instagram child sex accounts case
Meta owns Facebook, WhatsApp and Instagram. IllustrationBe among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once.
Time Business News
13 hours ago
- Time Business News
Pharma & Research Laboratories in Canada
Canada is recognized as a world leader in pharmaceutical research, development, and innovation. Highly equipped Pharmaceutical Laboratories and a regulatory structure that favours growth give the country a leading edge in medical and biotech advances. If you are a pharmaceutical company, healthcare provider, or a biotech start-up, the potential for partnerships with a reputable Canadian lab is both broad and profound. Pharmaceutical laboratories play a crucial role in developing safe and effective drugs and treatments for patients. These laboratories are key to: Conducting clinical research and trials. Developing new drugs and formulations. Maintaining compliance with quality standards and regulations. Advancing vaccine and biotechnology research. There are numerous reasons the world owes Pharma Laboratories a great debt for the company's significant contributions to public health. They are the unsung heroes of modern medicine, from cancer research to vaccine development. Lab Canada has been expanding at an unprecedented pace in the last few years. With strong government support, significant investment in research and development, and a highly skilled workforce, Canadian labs are making notable strides in pharmaceutical science. Canada is listed as one of the world's leaders in clinical trials, biologics research, and biotech innovation. The Canada lab has some of the best good manufacturing practices (GMP-compliant) and technology in the industry, which is unmatched anywhere. Many of these labs are also ISO-certified, meaning they adhere to international quality standards and maintain a safe testing environment. Most Canadian Pharmaceutical Laboratories Offer services that cater to all aspects of the pharmaceutical development cycle. These include: Analytical Services: Analysis for chemicals, stability testing, and testing of raw materials. Analysis for chemicals, stability testing, and testing of raw materials. Formulation: Dosage formulation including tablets, capsules, AND injectables, etc. Dosage formulation including tablets, capsules, AND injectables, etc. Microbiology Testing: Testing for harmful microorganisms in products. Testing for harmful microorganisms in products. Regulatory Submission: Supply relevant information for regulatory filings. Supply relevant information for regulatory filings. Bioavailability & Bioequivalence Studies: Efficacy of the drug being compared with the standard. From small batch testing to vast pharmaceutical manufacturing, be assured that Canadian Analytical Laboratories is our trusted partner in innovation and dependability. When choosing a laboratory, reliability, compliance, and innovation are non-negotiable. Here are some reasons why getting a Canadian lab is a good business decision: Elite Level Standards: Canadian labs comply with Health Canada & FDA standards. Canadian labs comply with Health Canada & FDA standards. Cutting-edge Technology: These laboratories are equipped with the best-of-breed tools, from AI-powered analytics to robotics automation. These laboratories are equipped with the best-of-breed tools, from AI-powered analytics to robotics automation. Expertise & Talent: With highly educated chemists, biologists, and lab techs, quality is a given. With highly educated chemists, biologists, and lab techs, quality is a given. Nut Data Integrity: Security and accuracy should be maintained in all testing activities. Security and accuracy should be maintained in all testing activities. Teamwork: Easily collaborate with research and manufacturing teams worldwide. Pharma Labs also services more than drug manufacturers. These include: Biotechnology Companies Healthcare Providers Nutraceutical Brands Academic and Research Institutions Veterinary Medicine Providers From diagnostics to commercial production, Laboratories Canada delivers tailored services to different industries. Laboratory needs continue to evolve in response to global health threats. Canada is investing heavily in AI for diagnostics, personalized medicine, and green chemistry. The future of Pharma Laboratories in Canada is bright, sustainable, and innovative. In today's fast-paced world, having the right partner can make all the difference when developing innovative pharmaceutical products. Pharma Laboratories Canada upholds the highest standards of quality, innovation, and compliance among its partnered drug developers and industry professionals in the pharmaceutical, biotechnology, and healthcare sectors. Whether you're introducing a new drug or in the process of testing, having a Canadian laboratory means your project is in reliable hands. When it comes to Research and Development, Canada laboratory represents trust, effectiveness, and innovation. Q1. What are the services provided by Pharma Laboratories in Canada? A: They provide analytical testing, formulation development, microbiology testing, support for clinical trials, and regulatory consulting. Q2. Do Canadian laboratories meet the international standard? A: Yes, most Canadian labs comply with GMP, ISO certifications, and follow FDA and Health Canada regulations. Q3. How Do I Find the Best Canadian Lab for My Project? A: Look at lab accreditation, experience, technology, turnaround times, and customer reviews. Q4. Do foreign pharmaceutical companies support Canadian labs? A: Absolutely, Canadian labs frequently partner with overseas clients and provide comprehensive services, including logistics, documentation, and regulatory applications. Q5. These labs are only for drugs? A: No, they additionally cater to the biotechnology, nutraceuticals, academic research, and veterinary sectors. TIME BUSINESS NEWS
Los Angeles Times
20 hours ago
- Los Angeles Times
Trump's tariff threat bolsters Lula in Brazil, hurts Bolsonaro
SíO PAULO — President Trump may have thought that pressuring Brazil with higher tariffs would help his far-right ally, former President Jair Bolsonaro, but the move has apparently backfired. Trump sent a letter this month to Brazilian President Luiz Inácio Lula da Silva threatening a 50% import tax and directly linking the decision to Bolsonaro's trial on charges related to his supporters' 2023 attack on the capital, which the U.S. president called a 'witch hunt.' 'This trial should end immediately!' Trump wrote Thursday evening in a second letter, this one addressed to Bolsonaro. He added that he had 'strongly voiced' his disapproval through his tariff policy. Rather than backing down, Brazil's Supreme Court escalated the case, worsening Bolsonaro's legal troubles. On Friday morning, federal police raided Bolsonaro's home and political office. The former president was ordered to wear an ankle monitor, banned from using social media and hit with other restrictions. Meanwhile, Lula — who had seen his popularity decline, growing opposition in Congress and increasing obstacles to another reelection bid — seems to have gained politically from the situation. Now the 79-year-old leftist Lula, in office for the third nonconsecutive term of his long political career, is seeing renewed acceptance, congressional support against Trump and pleas to run one last time to defend Brazil's sovereignty. Lula has appeared more energized in public since Trump's announcement. At a national students assembly Thursday, he wore a blue cap reading 'Sovereign Brazil Unites Us' — a contrast to Trump's red MAGA cap. 'A gringo will not give orders to this president,' he told the crowd, and called the tariff hike 'unacceptable blackmail.' The impact on Lula is not a first. Trump's actions targeting other countries have boosted ideological rivals in Canada and Australia instead of strengthening his allies at a local level. Private pollster Atlas said Tuesday that Lula's unpopularity had reversed course after his feud with Trump. Lula's job approval went from at 47.3% in June to 49.7% since the tariffs battle began, Atlas said. The poll of more than 2,800 people was conducted July 11to13, with a margin of error of 2 percentage points. The study also said 62.2% of Brazilians think the higher tariffs are unjustified, while 36.8% agree with the move. Even Bolsonaro's former vice president, Sen. Hamilton Mourão, criticized Trump's move as undue interference in Brazil's politics, though he said he joined the U.S. president in condemning the trial against the far-right leader. Social media analytics firm Palver analyzed 20,000 messages about Trump on WhatsApp, Brazil's most widely used communication platform, a day after Trump's announcement. Its analysis said right-wing users dominated viral content, but spontaneous conversations leaned left, mocking Bolsonaro as submissive and defending Brazil's sovereignty. 'Trump has put Lula back in the game,' said Thomas Traumann, an independent political consultant and former spokesman for the Brazilian presidency who only weeks ago argued that Lula had lost his front-runner status in the presidential race as he struggled to deliver on his promises on the economy. 'Trump handed it to Lula on a silver platter,' Traumann said. Business leaders who until recently sided with Bolsonaro are having to court Lula to negotiate with Trump. Agribusiness, Brazil's largest economic sector and a traditional right-wing stronghold, united to criticize the U.S. president's move. Industry groups were quick to denounce the tariffs as politically motivated and lacking commercial justification. 'In general, with the major exception of a more radical conservative wing, [Trump's move] generated national outrage for violating Brazil's sovereignty,' lawmaker Arnaldo Jardim, a member of the congressional agricultural caucus, told the Associated Press. Jardim, who pushed for the approval of a reciprocity bill that could be used by Lula if there's no agreement until the Aug. 1 deadline, hardly sides with the Brazilian leader. 'Even among sectors that initially thought this could benefit Bolsonaro, many had to reconsider their positions,' he said. Top congressional leaders who recently helped nix a Lula decree to raise a transactions tax were moving toward a head-on collision with him. After Trump's announcement, they signed a joint statement agreeing with Lula's promise to use the reciprocity law against the U.S. In another change, Brazil's Congress decided to start moving on Lula's plan to give an income tax break to millions of poorer Brazilians. Many politicians said that such an initiative was dead after Lula became the first president in three decades to have a decree annulled by lawmakers. At the Supreme Court, Bolsonaro is only getting deeper into trouble as his trial continues. Last week, Brazil's chief prosecutor called for a guilty verdict, accusing the former president of leading an armed criminal organization, attempting to stage a coup and attempting violent abolition of the democratic rule of law, among other charges. After Bolsonaro lost his reelection bid and Lula was inaugurated in January 2023, a mob of Bolsonaro supporters ransacked government buildings in Brasilia, injuring dozens of law enforcement officers. It was reminiscent of the insurrection at the U.S. Capitol two years earlier, in which a pro-Trump mob violently attacked the U.S. Capitol, killing and injuring police officers while trying to overturn Trump's election loss to Joe Biden. The defense will next likely present its case in the coming weeks, after which the panel of Supreme Court justices in the trial will vote on whether to convict or acquit him. The former president also suffered more consequences — the court's latest restrictions on Bolsonaro, including the ankle monitor, are part of a second investigation against one of his sons, Eduardo Bolsonaro, a Brazilian lawmaker who currently lives in the United States and is known for his close ties to Trump. He has been under scrutiny for allegedly working with U.S. authorities to impose sanctions against Brazilian officials. Supreme Court Justice Alexandre de Moraes, who oversees the criminal cases against Bolsonaro, said the Bolsonaros' actions attempted to pressure the Brazilian judiciary by involving the U.S. The court's decision cited both Trump's letter to Lula and several social media posts by the Bolsonaros in support of sanctions against Brazilian officials and speaking favorably about tariffs. 'A sovereign country like Brazil will always know how to defend its democracy and sovereignty,' De Moraes said. 'The judiciary will not allow any attempt to subject the functioning of the Supreme Court to the scrutiny of another state through hostile acts.' Jair Bolsonaro told journalists in Brasilia, the country's capital, that the ankle monitoring was a 'supreme humiliation.' 'I never thought about leaving Brazil, I never thought about going to an embassy, but the precautionary measures are because of that,' the former president said. In a statement, Eduardo Bolsonaro accused De Moraes of trying to criminalize Trump and the U.S. government. 'Since he has no power over them, he decided to make my father a hostage,' the younger Bolsonaro said of the judge. Pessoa and Savarese write for the Associated Press.
